You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RPC01-3201

Showing 1 - 25 of 218
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatitis, Atopic, Eczema Trial in Worldwide (CC-93538, Placebo)

Completed
  • Dermatitis, Atopic
  • Eczema
  • Birmingham, Alabama
  • +156 more
Dec 12, 2022

Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma Trial in Worldwide (Valemetostat Tosylate)

Recruiting
  • Relapsed/Refractory Peripheral T-Cell Lymphoma
  • Adult T Cell Leukemia/Lymphoma
  • Valemetostat Tosylate
  • Duarte, California
  • +59 more
Jun 3, 2022

Crohn Disease Trial in Worldwide (Ozanimod, Placebo)

Recruiting
  • Crohn Disease
  • Peoria, Arizona
  • +564 more
Aug 22, 2022

Eczema, Atopic Dermatitis Trial in Worldwide (KY1005, Placebo)

Active, not recruiting
  • Eczema
  • Atopic Dermatitis
  • Fremont, California
  • +102 more
Dec 13, 2022

Lymphoma, B-Cell Trial in Belgium, France (Valemetostat tosylate)

Recruiting
  • Lymphoma, B-Cell
  • Valemetostat tosylate
  • Bruges, Belgium
  • +21 more
Jan 9, 2023

Coronary Artery Disease (CAD) Trial in Worldwide (Ticagrelor, Acetylsalicylic Acid, Clopidogrel)

Completed
Has Results
  • Coronary Artery Disease (CAD)
  • Brisbane, Australia
  • +129 more
Mar 13, 2022

Ulcerative Colitis Trial in Worldwide (Ozanimod, Placebo)

Completed
Has Results
  • Ulcerative Colitis
  • Anaheim, California
  • +87 more
May 14, 2021

Plaque Psoriasis Trial in Worldwide (Adalimumab, ABP 501)

Completed
  • Plaque Psoriasis
  • Birmingham, Alabama
  • +87 more
Jan 4, 2023

Atopic Dermatitis Trial in Worldwide (Lebrikizumab, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Lebrikizumab
  • Placebo
  • Fort Smith, Arkansas
  • +93 more
Nov 2, 2022

Glaucoma, Acupuncture, Intraocular Pressure Trial in Taichung (Acupuncture, Acupuncture )

Not yet recruiting
  • Glaucoma
  • +2 more
  • Acupuncture
  • Acupuncture placebo
  • Taichung, Taiwan
    China Medical University Hospital
Mar 1, 2023

Psoriasis Trial in Worldwide (Humira®, BI 695501)

Completed
Has Results
  • Psoriasis
  • Birmingham, Alabama
  • +48 more
Jul 13, 2021

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Adult T-cell Leukemia/Lymphoma Trial in Japan (Valemetostat Tosylate)

Active, not recruiting
  • Adult T-cell Leukemia/Lymphoma
  • Valemetostat Tosylate
  • Nagoya-shi, Aichi, Japan
  • +23 more
Jan 11, 2022

Emphysema or COPD Trial in Germany (InterVapor®-System)

Not yet recruiting
  • Emphysema or Chronic Obstructive Pulmonary Disease
  • InterVapor®-System
  • Bamberg, Germany
  • +15 more
Feb 6, 2023

Relapsing Multiple Sclerosis Trial in Worldwide (Laquinimod)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Homewood, Alabama
  • +143 more
Dec 7, 2021

Ulcerative Colitis Trial in Worldwide (RPC1063, Placebo)

Completed
Has Results
  • Ulcerative Colitis
  • Sun City, Arizona
  • +371 more
Aug 6, 2021

Overactive Bladder (OAB) Trial in Worldwide (Detrol LA)

Completed
  • Overactive Bladder (OAB)
  • Detrol LA
  • Anaheim, California
  • +80 more
Jan 26, 2021

Multiple Sclerosis Trial in Worldwide (Laquinimod, Placebo, Avonex®)

Completed
Has Results
  • Multiple Sclerosis
  • Birmingham, Alabama
  • +169 more
Mar 23, 2022

Type 2 Diabetes Trial in Worldwide (Placebo of vildagliptin, vildagliptin, Metformin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Placebo of vildagliptin
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +227 more
Sep 1, 2020

Multiplex PCR -Microarray-based Assay in Detection of

Completed
  • Tuberculosis
  • Non-Tuberculous Mycobacterial Pneumonia
  • VereMTB
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Aug 7, 2022

Drug Exposure and Minimum Inhibitory Concentration in Treatment

Not yet recruiting
  • Mycobacterium Avium Complex
  • +3 more
  • Drug exposure
  • Shanghai, China
    Shanghai Pulmonary Hospital
Apr 10, 2023

Moderate-to-Severe Atopic Dermatitis Trial in Worldwide (Placebo, Nemolizumab)

Active, not recruiting
  • Moderate-to-Severe Atopic Dermatitis
  • Little Rock, Arkansas
  • +201 more
Aug 24, 2022

Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Buenos Aires, Santa Fe, Argentina
  • +186 more
Dec 17, 2020

Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon

Recruiting
  • Diabetes Mellitus, Type 2
  • +4 more
  • diabetes
  • Dschang, West Cameroon, Cameroon
  • +1 more
Jan 12, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

Terminated
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Boston, Massachusetts
  • +5 more
Jun 11, 2021